The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Calcium Signaling and Amyloid Toxicity in Alzheimer Disease
Open accessAbstract
Intracellular Ca(2+) signaling is fundamental to neuronal physiology and viability. Because of its ubiquitous roles, disruptions in Ca(2+) homeostasis are implicated in diverse disease processes and have become a major focus of study in multifactorial neurodegenerative diseases such as Alzheimer disease (AD). A hallmark of AD is the excessive production of beta-amyloid (Abeta) and its massive accumulation in amyloid plaques. In this minireview, we highlight the pathogenic interactions between altered cellular Ca(2+) signaling and Abeta in its different aggregation states and how these elements coalesce to alter the course of the neurodegenerative disease. Ca(2+) and Abeta intersect at several functional levels and temporal stages of AD, thereby altering neurotransmitter receptor properties, disrupting membrane integrity, and initiating apoptotic signaling cascades. Notably, there are reciprocal interactions between Ca(2+) pathways and amyloid pathology; altered Ca(2+) signaling accelerates Abeta formation, whereas Abeta peptides, particularly in soluble oligomeric forms, induce Ca(2+) disruptions. A degenerative feed-forward cycle of toxic Abeta generation and Ca(2+) perturbations results, which in turn can spin off to accelerate more global neuropathological cascades, ultimately leading to synaptic breakdown, cell death, and devastating memory loss. Although no cause or cure is currently known, targeting Ca(2+) dyshomeostasis as an underlying and integral component of AD pathology may result in novel and effective treatments for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Berridge, M. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80510-3 · Cited by 2,188
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Amyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,289
Terry, A. V., & Buccafusco, J. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041616 · Cited by 1,159
Amyloid Precursor Protein Trafficking, Processing, and Function
Thinakaran, G., & Koo, E. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800019200 · Cited by 1,141
Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer’s Disease
Busche, M. A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K.-H., Haass, C., Staufenbiel, M., Konnerth, A., & Garaschuk, O. (2008) · Science · doi:10.1126/science.1162844 · Cited by 1,125
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061
Demuro, A., Mina, E., Kayed, R., Milton, S. C., Parker, I., & Glabe, C. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500997200 · Cited by 1,041
Self-citationSoluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
Amyloid ion channels: A common structural link for protein-misfolding disease
Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J., & Lal, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502066102 · Cited by 982
Calcium dyshomeostasis and intracellular signalling in alzheimer's disease
LaFerla, F. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn960 · Cited by 978
Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972
Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host
Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E., Neuenschwander, A., Abramowski, D., Frey, P., Jaton, A. L., et al. (2006) · Science · doi:10.1126/science.1131864 · Cited by 971
Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease
Bezprozvanny, I., & Mattson, M. P. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.005 · Cited by 938
Arispe, N., Rojas, E., & Pollard, H. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.567 · Cited by 926
Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E., & Glabe, C. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400260200 · Cited by 902
Haes, A. J., Chang, L., Klein, W. L., & Van Duyne, R. P. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044087q · Cited by 864
β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity
Wang, H.-Y., Lee, D. H. S., D'Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5626 · Cited by 822
Structural Classification of Toxic Amyloid Oligomers
Glabe, C. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800016200 · Cited by 783
Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice
Kuchibhotla, K. V., Lattarulo, C. R., Hyman, B. T., & Bacskai, B. J. (2009) · Science · doi:10.1126/science.1169096 · Cited by 729
Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology
LIN, H., BHATIA, R., & LAL, R. (2001) · The FASEB Journal · doi:10.1096/fj.01-0377com · Cited by 644
Water-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains
Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., & Roher, A. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4077 · Cited by 618
Amyloid β-Protein Assembly and Alzheimer Disease
Roychaudhuri, R., Yang, M., Hoshi, M. M., & Teplow, D. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800036200 · Cited by 615
Kuchibhotla, K. V., Goldman, S. T., Lattarulo, C. R., Wu, H.-Y., Hyman, B. T., & Bacskai, B. J. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.008 · Cited by 614
What is the role of protein aggregation in neurodegeneration?
Ross, C. A., & Poirier, M. A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1742 · Cited by 604
Single‐channel recordings of three types of calcium channels in chick sensory neurones.
Fox, A. P., Nowycky, M. C., & Tsien, R. W. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016865 · Cited by 560
Arispe, N., Pollard, H. B., & Rojas, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10573 · Cited by 557
Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
Lansbury, P. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3342 · Cited by 553
Deshpande, A., Mina, E., Glabe, C., & Busciglio, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1189-06.2006 · Cited by 494
New Frontiers in Alzheimer's Disease Genetics
Tanzi, R. E., & Bertram, L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00476-7 · Cited by 463
Doody, R. S., Gavrilova, S. I., Sano, M., Thomas, R. G., Aisen, P. S., Bachurin, S. O., Seely, L., & Hung, D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61074-0 · Cited by 460
β-Amyloid Monomers Are Neuroprotective
Giuffrida, M. L., Caraci, F., Pignataro, B., Cataldo, S., De Bona, P., Bruno, V., Molinaro, G., Pappalardo, G., Messina, A., Palmigiano, A., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1736-09.2009 · Cited by 421
Calcium hypothesis of Alzheimer’s disease
Berridge, M. J. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0736-1 · Cited by 383
McLaurin, J., & Chakrabartty, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26482 · Cited by 335
Stutzmann, G. E., Smith, I., Caccamo, A., Oddo, S., LaFerla, F. M., & Parker, I. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0739-06.2006 · Cited by 329
Self-citationLinking Calcium to Aβ and Alzheimer's Disease
Green, K. N., & LaFerla, F. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.013 · Cited by 326
A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk
Dreses-Werringloer, U., Lambert, J.-C., Vingtdeux, V., Zhao, H., Vais, H., Siebert, A., Jain, A., Koppel, J., Rovelet-Lecrux, A., Hannequin, D., et al. (2008) · Cell · doi:10.1016/j.cell.2008.05.048 · Cited by 318
Buckingham, S. D., Jones, A. K., Brown, L. A., & Sattelle, D. B. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000562 · Cited by 308
Self-association of β-Amyloid Peptide (1–40) in Solution and Binding to Lipid Membranes
Terzi, E., Hölzemann, G., & Seelig, J. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0525 · Cited by 306
Xia, W., Zhang, J., Kholodenko, D., Citron, M., Podlisny, M. B., Teplow, D. B., Haass, C., Seubert, P., Koo, E. H., & Selkoe, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7977 · Cited by 284
Calcium Signal-induced Cofilin Dephosphorylation Is Mediated by Slingshot via Calcineurin
Wang, Y., Shibasaki, F., & Mizuno, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411494200 · Cited by 253
Kelly, B. L., & Ferreira, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605081200 · Cited by 241
Kremer, J. J., Pallitto, M. M., Sklansky, D. J., & Murphy, R. M. (2000) · Biochemistry · doi:10.1021/bi0001980 · Cited by 237
Lashuel, H. A., Hartley, D. M., Petre, B. M., Wall, J. S., Simon, M. N., Walz, T., & Lansbury, P. T. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00927-6 · Cited by 237
Amyloid beta peptides and glutamatergic synaptic dysregulation
Parameshwaran, K., Dhanasekaran, M., & Suppiramaniam, V. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.008 · Cited by 235
Frandsen, A., & Schousboe, A. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02031.x · Cited by 233
Soluble Amyloid Oligomers Increase Bilayer Conductance by Altering Dielectric Structure
Sokolov, Y., Kozak, J. A., Kayed, R., Chanturiya, A., Glabe, C., & Hall, J. E. (2006) · The Journal of General Physiology · doi:10.1085/jgp.200609533 · Cited by 228
Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease
Yankner, B. A., & Lu, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800018200 · Cited by 227
Activation of NF‐κB by ER stress requires both Ca2+ and reactive oxygen intermediates as messengers
Pahl, H. L., & Baeuerle, P. A. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00800-9 · Cited by 224
Nimmrich, V., Grimm, C., Draguhn, A., Barghorn, S., Lehmann, A., Schoemaker, H., Hillen, H., Gross, G., Ebert, U., & Bruehl, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4771-07.2008 · Cited by 210
Chakroborty, S., Goussakov, I., Miller, M. B., & Stutzmann, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2047-09.2009 · Cited by 207
Self-citationThe Pathogenesis of Alzheimers Disease—Is It a Lifelong “Calciumopathy”?
Stutzmann, G. E. (2007) · The Neuroscientist · doi:10.1177/1073858407299730 · Cited by 195
Self-citationHypothesis on the Regulation of Cytosol Calcium Concentration and the Aging Brain
Khachaturian, Z. S. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90073-x · Cited by 187
Preparation of Amyloid β‐Protein for Structural and Functional Studies
Teplow, D. B. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)13002-5 · Cited by 184
Avdulov, N. A., Chochina, S. V., Igbavboa, U., Warden, C. S., Vassiliev, A. V., & Wood, W. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041746.x · Cited by 180
Theoretical models of the ion channel structure of amyloid beta-protein
Durell, S. R., Guy, H. R., Arispe, N., Rojas, E., & Pollard, H. B. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80717-9 · Cited by 175
Acceleration of Amyloid β-Peptide Aggregation by Physiological Concentrations of Calcium
Isaacs, A. M., Senn, D. B., Yuan, M., Shine, J. P., & Yankner, B. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602061200 · Cited by 169
Phosphatidylinositol and inositol involvement in alzheimer amyloid-β fibril growth and arrest
McLaurin, J., Franklin, T., Chakrabartty, A., & Fraser, P. E. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1677 · Cited by 161
Wevers, A., Monteggia, L., Nowacki, S., Bloch, W., Schütz, U., Lindstrom, J., Pereira, E. F. R., Eisenberg, H., Giacobini, E., De Vos, R. A. I., et al. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00676.x · Cited by 158
Absence of cognitive impairment or decline in preclinical Alzheimer’s disease
Goldman, W. P., Price, J. L., Storandt, M., Grant, E., McKeel, D. W., Rubin, E. H., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.3.361 · Cited by 149
Kadir, A., Almkvist, O., Wall, A. E., Långström, B., & Nordberg, A. K. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0447-7 · Cited by 146
Sequence Determinants of Enhanced Amyloidogenicity of Alzheimer Aβ42 Peptide Relative to Aβ40
Kim, W., & Hecht, M. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505763200 · Cited by 146
MacManus, A., Ramsden, M., Murray, M., Henderson, Z., Pearson, H. A., & Campbell, V. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4713 · Cited by 138
Architecture of the Alzheimer?s A�P Ion Channel Pore
Arispe, N. J. (2004) · The Journal of Membrane Biology · doi:10.1007/s00232-003-0638-7 · Cited by 127
Memantine: targeting glutamate excitotoxicity in Alzheimer’s disease and other dementias
Molinuevo, J. L., Lladó, A., & Rami, L. (2005) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/153331750502000206 · Cited by 125
β-amyloid peptide decreases membrane fluidity
Müller, W. E., Koch, S., Eckert, A., Hartmann, H., & Scheuer, K. (1995) · Brain Research · doi:10.1016/0006-8993(94)01463-r · Cited by 124
Garaschuk, O., Schneggenburger, R., Schirra, C., Tempia, F., & Konnerth, A. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021255 · Cited by 122
Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice
Dewachter, I., Filipkowski, R. K., Priller, C., Ris, L., Neyton, J., Croes, S., Terwel, D., Gysemans, M., Devijver, H., Borghgraef, P., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.011 · Cited by 122
Amyloid-β-(1-42) Increases Ryanodine Receptor-3 Expression and Function in Neurons of TgCRND8 Mice
Supnet, C. B., Grant, J., Kong, H., Westaway, D. A., & Mayne, M. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606736200 · Cited by 116
Díaz, J. C., Šimáková, O., Jacobson, K. A., Arispe, N. J., & Pollard, H. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813355106 · Cited by 116
Amyloid-β-Induced Ion Flux in Artificial Lipid Bilayers and Neuronal Cells: Resolving a Controversy
Capone, R. F., Quiroz, F. G., Prangkio, P., Saluja, I., Sauer, A., Bautista, M. R., Turner, R. S., Yang, J., & Mayer, M. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9033-1 · Cited by 115
Pollard, H. B., Rojas, E., & Arispe, N. J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23046.x · Cited by 111
Avdulov, N. A., Chochina, S. V., Igbavboa, U., O‘Hare, E., Schroeder, F., Cleary, J. P., & Wood, W. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052086.x · Cited by 106
Selective induction of calcineurin activity and signaling by oligomeric amyloid beta
Reese, L. C., Zhang, W.-R., Dineley, K. T., Kayed, R., & Taglialatela, G. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00434.x · Cited by 105
Geerts, H., & Grossberg, G. T. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006288734 · Cited by 101
Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-β peptide
Casley, C. S., Lakics, V., Lee, H., Broad, L. M., Day, T. A., Cluett, T., Smith, M. A., O’Neill, M. J., & Kingston, A. E. (2009) · Brain Research · doi:10.1016/j.brainres.2008.12.082 · Cited by 98
Jang, H., Ma, B., Lal, R., & Nussinov, R. (2008) · Biophysical Journal · doi:10.1529/biophysj.108.134551 · Cited by 95
All-D-Enantiomers of β-Amyloid Exhibit Similar Biological Properties to All-L-β-Amyloids
Cribbs, D. H., Pike, C. J., Weinstein, S. L., Velázquez, P., & Cotman, C. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7431 · Cited by 93
Shemer, I., Holmgren, C. D., Min, R., Fülöp, L., Zilberter, M. Y., Sousa, K. M., Farkas, T., Härtig, W., Penke, B., Burnashev, N., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04733.x · Cited by 89
Tsai, S., Hong, C., Liu, H.-C., Liu, T., Hsu, L.-E., & Lin, C. (2004) · Neuropsychobiology · doi:10.1159/000075332 · Cited by 79
Bridging Physiology and Pathology in AD
Kim, D., & Tsai, L. (2009) · Cell · doi:10.1016/j.cell.2009.05.042 · Cited by 74
Aβ(25–35) and Aβ(1–40) act on different calcium channels in CA1 hippocampal neurons
Rovira, C., Arbez, N., & Mariani, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02072-7 · Cited by 71
Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscle
Shtifman, A., Ward, C. W., Laver, D. R., Bannister, M. L., Lopez, J. R., Kitazawa, M., LaFerla, F. M., Ikemoto, N., & Querfurth, H. W. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.11.003 · Cited by 64
Korkotian, E., & Segal, M. (2006) · Cell Calcium · doi:10.1016/j.ceca.2006.11.006 · Cited by 60
Schapansky, J., Olson, K. L., der Ploeg, R. V., & Glazner, G. W. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.04.009 · Cited by 44
In situAbetapores in AD brain are cylindrical assembly of Abetaprotofilaments
Inoué, S. (2008) · Amyloid · doi:10.1080/13506120802524858 · Cited by 44
Membrane destabilization induced by β-amyloid peptide 29-42: Importance of the amino-terminus
Mingeot‐Leclercq, M., Lins, L., Bensliman, M., Françoise Van Bambeke, A., Smissen, P. V. D., Peuvot, J., Schanck, A. N., & Brasseur, R. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00108-1 · Cited by 39
Mattson, M. P., & Furukawa, K. (1997) · APOPTOSIS · doi:10.1023/a:1026433019210 · Cited by 32
Effects of amyloid-β peptides on the serotoninergic 5-HT1A receptors in the rat hippocampus
Verdurand, M., Bérod, A., Bars, D. L., & Zimmer, L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.008 · Cited by 31
Electrophysiological effects of 25–35 amyloid-β-protein on guinea-pig lateral septal neurons
Carette, B., Poulain, P., & Delacourte, A. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90059-t · Cited by 30
Shaked, G. M., Chauv, S., Ubhi, K. K., Hansen, L. A., & Masliah, E. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06997.x · Cited by 28
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“…oligomers are the primary neurotoxic substances, 131 – 133 disruption of cell membrane integrity, 134 activation in in fl ammatory responses, 135,136 causes of calcium homeostasis imbalance 137 and mitochondrial dysfunction, 138 – 140 triggers in oxidative stress, 141 and damage factor of synapses.”
BackgroundFricker, M., Tolkovsky, A. M., Borutaite, V., Coleman, M., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,108
The case for rejecting the amyloid cascade hypothesis
Herrup, K. (2015) · Nature Neuroscience · doi:10.1038/nn.4017 · Cited by 768
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Metadata
- Authors
- Demuro, A., Parker, I., & Stutzmann, G. E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 285
- Issue
- 17
- Pages
- 12463-12468
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2009828191
- Cited by
- 407
- References
- 98
- FWCI
- 21.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.